Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter/half year ended September 30 ,2024